Title: Dialysis-Related Amyloidosis Treatment Act of 2020
Policy area: Health

Summary:
Dialysis-Related Amyloidosis Treatment Act of 2020
This bill provides for Medicare coverage and payment of treatments for dialysis-related amyloidosis (a complication of kidney failure that can occur as a result of long-term dialysis).

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8652 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 8652

To amend title XVIII of the Social Security Act to provide coverage and 
 payment under such title for certain treatments for dialysis-related 
                  amyloidosis, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            October 23, 2020

  Mr. Babin introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to provide coverage and 
 payment under such title for certain treatments for dialysis-related 
                  amyloidosis, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Dialysis-Related Amyloidosis 
Treatment Act of 2020''.

SEC. 2. COVERAGE AND PAYMENT FOR TREATMENTS FOR DIALYSIS-RELATED 
              AMYLOIDOSIS UNDER THE MEDICARE PROGRAM.

    (a) Coverage.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)), is amended--
            (1) in subparagraph (GG), by striking ``and'' at the end;
            (2) in subparagraph (HH), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following new subparagraph:
            ``(II) treatments for dialysis-related amyloidosis (as 
        defined in subsection (kkk)).''.
    (b) Treatments for Dialysis-Related Amyloidosis Defined.--
            (1) In general.--Section 1861 of the Social Security Act 
        (42 U.S.C. 1395x), is amended by adding at the end the 
        following new subsection:
    ``(kkk) Treatments for Dialysis-Related Amyloidosis.--The term 
`treatments for dialysis-related amyloidosis' means any item or service 
that is furnished in a dialysis facility (freestanding or hospital-
based) that is approved by the Food and Drug Administration for the 
treatment of dialysis-related amyloidosis, and any supplies or services 
that are provided adjunct to and are necessary for such treatment.''.
            (2) Exclusion from renal dialysis services.--Section 
        1881(b)(14)(B) of the Social Security Act (42 U.S.C. 
        1395rr(b)(14)(B)) is amended by inserting before the period at 
        the end the following: ``or `treatments for dialysis-related 
        amyloidosis' (as defined in section 1861(kkk))''.
    (c) Payment.--Section 1833(a)(1)(E) of the Social Security Act (42 
U.S.C. 1395l(a)(1)(E)) is amended by inserting at the end the 
following: ``except for treatments for dialysis-related amyloidosis, 
which may not be included as a renal dialysis service for purposes of 
payment under any prospective payment amount or comprehensive fee 
established under section 1881, and for which payment shall be made 
separately in the amount of 100 percent of the reasonable charges for 
such items and services,''.
    (d) Effective Date.--The amendments made by this section shall take 
effect on the date of the enactment of this Act.
                                 <all>